Here are five things to know:
1. Michael A. McManus, Jr., will step down from his positions as director and chairman of the board of directors as well as president and CEO.
2. Stavros G. Vizirgianakis, a member of Misonix’s board of directors, will fill Mr. McManus’ place as the interim CEO.
3. Misonix is currently pursuing options with Mr. Vizirgianakis to fill the full-time position of CEO.
4. Mr. Vizirgianakis has served on the board since May 2013 and has a 5.7 percent ownership state in the company.
5. Misonix develops ultrasonic products for spine surgery, neurosurgery, wound debridement, skull base surgery and laparoscopic surgery, among other applications.
More articles on devices:
J&J, SI-BONE, Medtronic & more: 10 key notes
Global wearable health sensors market to hit $48.6M by 2018: 4 observations
Global orthopedic implants market to hit $6.2B by 2024 — 7 points
